The prophylactic use of hydroxychloroquine was associated with some protection level (p=0.059), which was not statistically significant. With its in-vitro effectivity against SARS-CoV-2 and good lung concentration, hydroxychloroquine is a drug candidate selected to be used as prophylaxis against COVID-19 [13-15]. But the actual protection level is still unknown, and it is to be established by larger studies. It was found in the study that the alternative medicines were effective against COVID-19 while taken as prophylaxis. These medications are considered as immunity boosters and used by a larger portion of society in this subcontinent, though the actual form of the alternative medications was not enquired of in this study. We do not conclude about the prophylactic role of these medications here as the possible reason for the apparent protection conferred by the alternative medications might lie in the fact that people exercising such measures are more conscious about other preventive practices like mask use and social distancing, which are proven to be effective in preventing the transmission of COVID-19.